DOI QR코드

DOI QR Code

Improvement of Peak Cough Flow After the Application of a Mechanical In-exsufflator in Patients With Neuromuscular Disease and Pneumonia: A Pilot Study

  • Jung, Ji Ho (Department of Rehabilitation Medicine and Rehabilitation Institute of Neuromuscular Disease, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Oh, Hyeon Jun (Department of Rehabilitation Medicine and Rehabilitation Institute of Neuromuscular Disease, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Lee, Jang Woo (Department of Physical Medicine and Rehabilitation, National Health Insurance Service Ilsan Hospital) ;
  • Suh, Mi Ri (Department of Rehabilitation Medicine and Rehabilitation Institute of Neuromuscular Disease, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Park, Jihyun (Department of Rehabilitation Medicine and Rehabilitation Institute of Neuromuscular Disease, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Choi, Won Ah (Department of Rehabilitation Medicine and Rehabilitation Institute of Neuromuscular Disease, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Kang, Seong-Woong (Department of Rehabilitation Medicine and Rehabilitation Institute of Neuromuscular Disease, Gangnam Severance Hospital, Yonsei University College of Medicine)
  • Received : 2018.05.21
  • Accepted : 2018.06.26
  • Published : 2018.12.31

Abstract

Objective To investigate and demonstrate persistent increase of peak cough flow after mechanical in-exsufflator application, in patients with neuromuscular diseases and pneumonia. Methods A mechanical in-exsufflator was applied with patients in an upright or semi-upright sitting position (pressure setting, +40 and $-40cmH_2O$; in-exsufflation times, 2-3 and 1-2 seconds, respectively). Patients underwent five cycles, with 20-30 second intervals to prevent hyperventilation. Peak cough flow without and with assistive maneuvers, was evaluated before, and 15 and 45 minutes after mechanical in-exsufflator application. Results Peak cough flow was 92.6 L/min at baseline, and 100.4 and 100.7 L/min at 15 and 45 minutes after mechanical in-exsufflator application, respectively. Assisted peak cough flow at baseline, 15 minutes, and 45 minutes after mechanical in-exsufflator application was 170.7, 179.3, and 184.1 L/min, respectively. While peak cough flow and assisted peak cough flow increased significantly at 15 minutes after mechanical in-exsufflator application compared with baseline (p=0.030 and p=0.016), no statistical difference was observed between 15 and 45 minutes. Conclusion Increased peak cough flow after mechanical in-exsufflator application persists for at least 45 minutes.

Keywords

References

  1. Bach JR, Ishikawa Y, Kim H. Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest 1997;112:1024-8. https://doi.org/10.1378/chest.112.4.1024
  2. Lechtzin N, Wiener CM, Clawson L, Chaudhry V, Diette GB. Hospitalization in amyotrophic lateral sclerosis: causes, costs, and outcomes. Neurology 2001;56:753-7. https://doi.org/10.1212/WNL.56.6.753
  3. Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 2005;12:921-38. https://doi.org/10.1111/j.1468-1331.2005.01351.x
  4. Bach JR. Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory AIDS. Chest 2002;122:92-8. https://doi.org/10.1378/chest.122.1.92
  5. Inkley SR, Oldenburg FC, Vignos PJ Jr. Pulmonary function in Duchenne muscular dystrophy related to stage of disease. Am J Med 1974;56:297-306. https://doi.org/10.1016/0002-9343(74)90611-1
  6. Rideau Y, Gatin G, Bach J, Gines G. Prolongation of life in Duchenne's muscular dystrophy. Acta Neurol (Napoli) 1983;5:118-24.
  7. Vignos PJ Jr. Respiratory function and pulmonary infection in Duchenne muscular dystrophy. Isr J Med Sci 1977;13:207-14.
  8. Bach JR. Amyotrophic lateral sclerosis: predictors for prolongation of life by noninvasive respiratory aids. Arch Phys Med Rehabil 1995;76:828-32. https://doi.org/10.1016/S0003-9993(95)80547-8
  9. Bach JR. Mechanical insufflation-exsufflation. Comparison of peak expiratory flows with manually assisted and unassisted coughing techniques. Chest 1993;104:1553-62. https://doi.org/10.1378/chest.104.5.1553
  10. Chatwin M, Ross E, Hart N, Nickol AH, Polkey MI, Simonds AK. Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness. Eur Respir J 2003;21:502-8. https://doi.org/10.1183/09031936.03.00048102
  11. Sancho J, Servera E, Diaz J, Marin J. Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. Chest 2004;125:1400-5. https://doi.org/10.1378/chest.125.4.1400
  12. Winck JC, Goncalves MR, Lourenco C, Viana P, Almeida J, Bach JR. Effects of mechanical insufflationexsufflation on respiratory parameters for patients with chronic airway secretion encumbrance. Chest 2004;126:774-80. https://doi.org/10.1378/chest.126.3.774
  13. Fauroux B, Guillemot N, Aubertin G, Nathan N, Labit A, Clement A, et al. Physiologic benefits of mechanical insufflation-exsufflation in children with neuromuscular diseases. Chest 2008;133:161-8. https://doi.org/10.1378/chest.07-1615
  14. Bach JR. Update and perspective on noninvasive respiratory muscle aids. Part 2. The expiratory aids. Chest 1994;105:1538-44. https://doi.org/10.1378/chest.105.5.1538
  15. Sinha R, Bergofsky EH. Prolonged alteration of lung mechanics in kyphoscoliosis by positive pressure hyperinflation. Am Rev Respir Dis 1972;106:47-57. https://doi.org/10.1164/arrd.1972.106.1.47
  16. Lechtzin N, Shade D, Clawson L, Wiener CM. Supramaximal inflation improves lung compliance in subjects with amyotrophic lateral sclerosis. Chest 2006;129:1322-9. https://doi.org/10.1378/chest.129.5.1322
  17. Chatwin M. How to use a mechanical insufflator-exsufflator "cough assist machine". Breathe 2008;4:320-9.